Acumen Pharmaceuticals, Inc. (ABOS): Weighted Average Diluted Shares
60.56M
Year ended 2025-12-31
+14.3%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 60.56M | +0.9% | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | 60.01M | +23.5% | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | 48.61M | +19.7% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | 40.60M | n/c | 2024-03-26, From 2022-01-01 |
| 2021-12-31 | 20.06M | n/a | 2023-03-27, From 2021-01-01 |